Fargo, N.D.-based Sharp Biomedical, a spinal medtech company, has closed a pre-seed funding round.
Sharp Biomedical will use the funding for the development and testing pathway necessary to bring its first purpose-built spinal toolset and implant system to market, according to an Oct. 12 news release from Sharp Biomedical.
The company focuses on creating novel, streamlined toolsets and implants for spinal care, allowing physicians and outpatient clinics to treat early-to-mid-stage chronic pain.
The funding round was led by gener8tor 1889, a North Dakota-based venture capital fund, with participation from physician angel investors, the release said.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.
